After April 1, can COVID-19's medicines be reimbursed by medical insurance?

According to the regulations issued by the National Medical Insurance Bureau, from April 2002 1 year to April 20021year, COVID-19's medical and treatment expenses continued to be included in the scope of medical insurance payment, and were fully reimbursed.

Since the outbreak of the COVID-19 epidemic in early 2020, the Chinese government has taken a series of measures to curb the spread of the epidemic, including full or partial reimbursement of medical expenses in COVID-19. Up to now, COVID-19's medical treatment expenses have been included in the scope of medical insurance payment and enjoy full reimbursement. In view of "After April 1, can COVID-19 Medicine still be reimbursed for medical insurance?" For this problem, according to the regulations issued by the National Medical Insurance Bureau, from April 2002 1 day to April1day, the medical expenses in COVID-19 will continue to be included in the scope of medical insurance payment and be fully reimbursed. In addition, according to the relevant regulations and policies of the local health care department, relevant COVID-19 drugs can also be applied for inclusion in the scope of medical insurance payment. It should be noted that the medical and treatment expenses in COVID-19, which are included in the scope of medical insurance payment, must comply with the relevant national and local regulations and standards and cannot exceed the local medical service price level. In addition, drugs included in the scope of medical insurance payment must go through strict examination and approval procedures and evaluation to ensure their safety and effectiveness.

What should I do if I have difficulty applying for medical insurance reimbursement? If you encounter difficulties in applying for medical insurance reimbursement, it is recommended to consult the local health care department in time to understand the relevant policies and regulations. If it can't be solved, you can complain to the local medical insurance bureau or the civil affairs department for help. At the same time, you can also seek the help of professional lawyers to safeguard your rights and interests.

From April 2002 1 day to April1day, the medical expenses in COVID-19 continued to be included in the scope of medical insurance payment and were fully reimbursed. COVID-19 drugs included in the scope of medical insurance payment can also apply for reimbursement, but they must comply with relevant regulations and standards. For the problems encountered in applying for medical insurance reimbursement, it is necessary to consult local health care departments or lawyers and other professionals in time to safeguard their own rights and interests.

Legal basis:

Interim Measures for the Administration of Designated Medical Institutions of Basic Medical Insurance for Urban Employees Fifteenth social insurance agencies should strengthen the inspection and audit of medical expenses of insured persons in designated medical institutions. Designated medical institutions have the obligation to provide all the medical information and account list required for the audit of medical expenses. Sixteenth social insurance agencies shall, in accordance with the relevant policies and regulations of basic medical insurance and the agreements signed with designated medical institutions, settle medical expenses with designated medical institutions on time and in full. Do not meet the requirements of medical expenses, social insurance agencies will not pay.